The Lancet Neurology
订阅
1. [Comment] Targeting B cells in neuromyelitis optica spectrum disorder Chao Zhang, Fu-Dong Shi
2. [Comment] Stopping haematoma growth: the search for the right time, place, and agent Sabine Voigt, Marieke J H Wermer
3. [Personal View] Climate change and disorders of the nervous system Sanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, James D Mills, Ethan Haynes, Elvira Bramon, Paul Chadwick, Olga Ciccarelli, Anthony S David, Kris De Meyer, Nick C Fox, Joanna Davan Wetton, Martin Koltzenburg, Dimitri M Kullmann, Manju A Kurian, Hadi Manji, Mark A Maslin, Manjit Matharu, Hugh Montgomery, Marina Romanello, David J Werring, Lisa Zhang, Karl J Friston, Michael G Hanna
4. [Editorial] Forging ahead in haemorrhagic stroke research The Lancet Neurology
5. [In Context] SARS-CoV-2 infection as a cause of neurodegeneration Daniel Bonhenry, Mirren Charnley, Jorge Gonçalves, Per Hammarström, Michael T Heneka, Ruth Itzhaki, Jean-Charles Lambert, Misbah Mannan, Abdul Mannan Baig, Jinte Middeldorp, Sofie Nyström, Nicholas P Reynolds, Maria Stefanatou, Joshua T Berryman
6. [In Context] The torment of needing to know for sure Andrew J Lees
7. [Comment] Neurology and climate change Larry Junck, Ali Saad, Bret Andrews
8. [In Context] Thien Phu Do
9. [Rapid Review] B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
10. [In Context] Pooja Khatri: driven by appreciation and gratitude Priya Venkatesan
11. [Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease – Author's reply Andrew McGarry
12. [Corrections] Correction to Lancet Neurol 2024; 23: 465–76
13. [Correspondence] The prescription of valproate: risk of harm Fergus Rugg-Gunn, David Hunt
14. [Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease Thomas Müller, Jan Dominique Möhr
15. [Correspondence] The prescription of valproate: risk of harm Alison Cave
16. [Comment] Speculation on the transmissibility of Alzheimer's disease Alifiya Kapasi, Julie A Schneider
17. [Comment] Elucidating a new path of CSF transport in the CNS Helene Benveniste, Jean-Leon Thomas
18. [Review] Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features Mariam Ali, Ellis S van Etten, Saloua Akoudad, Joanna D Schaafsma, Marieke C Visser, Mahsoem Ali, Charlotte Cordonnier, Else Charlotte Sandset, Catharina J M Klijn, Ynte M Ruigrok, Marieke J H Wermer
19. [Comment] Cerebral cavernous malformations: to operate or not? Gabriël J E Rinkel
20. [Articles] Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier, Ari J Green, Orhan Aktas, Hans-Peter Hartung, Dewei She, William Rees, Michael Smith, Daniel Cimbora, Eliezer Katz, Jeffrey L Bennett, N-MOmentum study investigators
21. [In Context] The Egyptian origins of neuroanatomy Emmanuel Drouin, Arnaud Kwiatkowski, Patrick Hautecoeur
22. [Articles] Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial Nawaf Yassi, Henry Zhao, Leonid Churilov, Teddy Y Wu, Henry Ma, Huy-Thang Nguyen, Andrew Cheung, Atte Meretoja, Duy Ton Mai, Timothy Kleinig, Jiann-Shing Jeng, Philip M C Choi, Phuc Dang Duc, Helen Brown, Annemarei Ranta, Neil Spratt, Geoffrey C Cloud, Hao-Kuang Wang, Rohan Grimley, Karim Mahawish, Der-Yang Cho, Darshan Shah, Thai My Phuong Nguyen, Gagan Sharma, Vignan Yogendrakumar, Bernard Yan, Emma L Harrison, Michael Devlin, Dennis Cordato, Nicolas Martinez-Majander, Daniel Strbian, Vincent Thijs, Lauren M Sanders, David Anderson, Mark W Parsons, Bruce C V Campbell, Geoffrey A Donnan, Stephen M Davis, STOP-MSU Trial Investigators
23. [Corrections] Correction to Lancet Neurol 2024; 23: 393–403
24. [Articles] Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial CARE pilot trial collaboration
25. [Comment] New gene involved in the pathogenesis of Parkinson's disease Mathias Toft
26. [Articles] RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses Emil K Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D Fox, Silke Appel-Cresswell, A Jon Stoessl, Alex Rajput, Ali H Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B Haack, Suzanne Lesage, Christelle Tesson, Alexis Brice, Carles Vilariño-Güell, Mina Ryten, Matthew S Goldberg, Andrew B West, Michele T Hu, Huw R Morris, Manu Sharma, Ziv Gan-Or, Bedia Samanci, Pawel Lis, Maria Teresa Periñan, Rim Amouri, Samia Ben Sassi, Faycel Hentati, Global Parkinson's Genetics Program (GP2), Francesca Tonelli, Dario R Alessi, Matthew J Farrer
更新于 16 分钟前

近期历史最近 100 条记录

2024-05-16 [Comment] Targeting B cells in neuromyelitis optica spectrum disorder Chao Zhang, Fu-Dong Shi
2024-05-16 [Comment] Stopping haematoma growth: the search for the right time, place, and agent Sabine Voigt, Marieke J H Wermer
2024-05-16 [Personal View] Climate change and disorders of the nervous system Sanjay M Sisodiya, Medine I Gulcebi, Francesco Fortunato, James D Mills, Ethan Haynes, Elvira Bramon, Paul Chadwick, Olga Ciccarelli, Anthony S David, Kris De Meyer, Nick C Fox, Joanna Davan Wetton, Martin Koltzenburg, Dimitri M Kullmann, Manju A Kurian,
2024-05-16 [Editorial] Forging ahead in haemorrhagic stroke research The Lancet Neurology
2024-05-16 [In Context] SARS-CoV-2 infection as a cause of neurodegeneration Daniel Bonhenry, Mirren Charnley, Jorge Gonçalves, Per Hammarström, Michael T Heneka, Ruth Itzhaki, Jean-Charles Lambert, Misbah Mannan, Abdul Mannan Baig, Jinte Middeldorp, Sofie Nyström, Nicholas P Reynolds, Maria Stefanatou, Joshua T Berryman
2024-05-16 [In Context] The torment of needing to know for sure Andrew J Lees
2024-05-16 [Comment] Neurology and climate change Larry Junck, Ali Saad, Bret Andrews
2024-05-16 [In Context] Thien Phu Do
2024-05-16 [Rapid Review] B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
2024-05-16 [In Context] Pooja Khatri: driven by appreciation and gratitude Priya Venkatesan
2024-05-16 [Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease – Author's reply Andrew McGarry
2024-05-16 [Corrections] Correction to Lancet Neurol 2024; 23: 465–76
2024-05-16 [Correspondence] The prescription of valproate: risk of harm Fergus Rugg-Gunn, David Hunt
2024-05-16 [Correspondence] Negative findings from trials with NLY01 or deferiprone for Parkinson's disease Thomas Müller, Jan Dominique Möhr
2024-05-16 [Correspondence] The prescription of valproate: risk of harm Alison Cave
2024-05-16 [Comment] Speculation on the transmissibility of Alzheimer's disease Alifiya Kapasi, Julie A Schneider
2024-05-16 [Comment] Elucidating a new path of CSF transport in the CNS Helene Benveniste, Jean-Leon Thomas
2024-05-16 [Review] Haemorrhagic stroke and brain vascular malformations in women: risk factors and clinical features Mariam Ali, Ellis S van Etten, Saloua Akoudad, Joanna D Schaafsma, Marieke C Visser, Mahsoem Ali, Charlotte Cordonnier, Else Charlotte Sandset, Catharina J M Klijn, Ynte M Ruigrok, Marieke J H Wermer
2024-05-16 [Comment] Cerebral cavernous malformations: to operate or not? Gabriël J E Rinkel
2024-05-16 [Articles] Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary R Cutter, Romain Marignier, Ari J Green, Orhan Aktas, Hans-Peter Hartung, Dewei She, William Rees, Michael Smith, Daniel Cimbora, Eli
2024-05-16 [In Context] The Egyptian origins of neuroanatomy Emmanuel Drouin, Arnaud Kwiatkowski, Patrick Hautecoeur
2024-05-16 [Articles] Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial Nawaf Yassi, Henry Zhao, Leonid Churilov, Teddy Y Wu, Henry Ma, Huy-Thang Nguyen, Andrew Cheung, Atte Meretoja, Duy Ton Mai, Timothy Kleinig, Jiann-Shing Jeng, Philip M C Choi, Phuc Dang Duc, Helen Brown, Annemarei Ranta, Neil Spratt, Geoffrey C Cloud, Ha
2024-05-16 [Corrections] Correction to Lancet Neurol 2024; 23: 393–403
2024-05-16 [Articles] Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial CARE pilot trial collaboration
2024-05-16 [Articles] RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses Emil K Gustavsson, Jordan Follett, Joanne Trinh, Sandeep K Barodia, Raquel Real, Zhiyong Liu, Melissa Grant-Peters, Jesse D Fox, Silke Appel-Cresswell, A Jon Stoessl, Alex Rajput, Ali H Rajput, Roland Auer, Russel Tilney, Marc Sturm, Tobias B Haack, Suzan
2024-05-16 [Comment] New gene involved in the pathogenesis of Parkinson's disease Mathias Toft
2024-04-16 [Correspondence] The need for partnerships in migration for medical workers Caroline Theoharides
2024-04-16 [Correspondence] The African Stroke Organization Conference 2023 Fred Stephen Sarfo, Mehari Gebreyohanns, Rufus Akinyemi, Ad Adams Ebenezer, Bruce Ovbiagele, Mayowa Owolabi, ASOC 2023 Planning Committee
2024-04-16 [Comment] Surrogate endpoints for progressive multifocal leukoencephalopathy Joep Killestein, Mike P Wattjes
2024-04-16 [Comment] Factors affecting brain maturation trajectories in early childhood Thiviya Selvanathan, Steven P Miller
2024-04-16 [Comment] Insights into the progression of genetic Alzheimer's disease from tau PET Agneta Nordberg
2024-04-16 [Comment] Association of Pick's disease with the MAPT H2 haplotype Gaël Nicolas
2024-04-16 [Comment] A disease-specific therapy in facioscapulohumeral muscular dystrophy Nicol Voermans, John Vissing
2024-04-16 [Correspondence] Dementia prevention: from idealism to realism Abolfazl Avan, Vladimir Hachinski
2024-04-16 [In Context] Felicia Bliss Axelrod: the dysautonomia pioneer Maria Trinidad Herrero
2024-04-16 [Personal View] Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials Irene Cortese, Gina Norato, Patrick R Harrington, Therri Usher, Ilaria Mainardi, Guillaume Martin-Blondel, Paola Cinque, Eugene O Major, Virginia Sheikh
2024-04-16 [Review] Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment Michael C Ferraro, Neil E O’Connell, Claudia Sommer, Andreas Goebel, Janet H Bultitude, Aidan G Cashin, G Lorimer Moseley, James H McAuley
2024-04-16 [Editorial] Important lessons on healthcare from rare diseases The Lancet Neurology
2024-04-16 [Articles] Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study Julie K Wisch, Nicole S McKay, Anna H Boerwinkle, James Kennedy, Shaney Flores, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid E O’Bryant, Julie C Price, Charles M Laymon, Sharon J Krinsky-McHale, Florence Lai,
2024-04-16 [Review] Improving epilepsy diagnosis across the lifespan: approaches and innovations Jacob Pellinen, Emma C Foster, Jo M Wilmshurst, Sameer M Zuberi, Jacqueline French
2024-04-16 [Articles] Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland, Leo H Wang, Angela Genge, Sabrina Sacconi, Hanns Lochmüller, David Reyes-Leiva, Jordi Diaz-Manera, Jorge Alonso-Perez, Nuria Muelas, Juan J Vilchez, Alan Pestronk, Summer Gi
2024-04-16 [Articles] MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study Rebecca R Valentino, William J Scotton, Shanu F Roemer, Tammaryn Lashley, Michael G Heckman, Maryam Shoai, Alejandro Martinez-Carrasco, Nicole Tamvaka, Ronald L Walton, Matthew C Baker, Hannah L Macpherson, Raquel Real, Alexandra I Soto-Beasley, Kin Mok,
2024-04-16 [In Context] A neurotransmitter with a fascinating story Jennifer Pocock
2024-04-16 [In Context] What we remember Marco De Ambrogi
2024-04-16 [In Context] Fostering diversity, equity, and inclusion in Europe Marianne de Visser, Elena Moro
2024-04-16 [In Context] Violiza Inoa
2024-04-16 [Corrections] Correction to Lancet Neurol 2024; 23: 344–81
2024-04-16 [Articles] Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial Alberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, Alberto Albanese, Aaron Ellenbogen, Joaquim J Ferreira, Nir Giladi, Tanya Gurevich, Sharon Hassin-Baer, Jorge Hernandez-Vara, Stuart H Isaacson, Karl Kieburtz, Peter A LeWitt, Lydia Lopez-Manzanares, C Warr
2024-04-16 [Comment] Fluctuations in Parkinson's disease: progress and challenges Francisco Cardoso, Eduardo Tolosa

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选